Global Coalition for Adaptive Research

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma	Disease Attributes, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 2 / Phase 3	2026-10-01	NCT03970447
Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone	Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder	Not yet recruiting	Phase 2	2026-05-20	NCT05948579
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia	COVID-19, Community-Acquired Infections, Community-Acquired Pneumonia, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, influenza, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Recruiting	Phase 3	2024-07-12	NCT02735707

Clinical trials